Send us Feedback

Syngenta AG (SYT)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

SYT » Topics » septoria

This excerpt taken from the SYT 6-K filed Jul 28, 2005.
septoria resistance and in eastern Europe where sales again showed double digit growth in these rapidly expanding markets. Elsewhere, sales were affected by unfavorable weather conditions, with a cold start to the season followed by drought in southern Europe, notably Spain.

In

This excerpt taken from the SYT 6-K filed Feb 15, 2005.
septoria resistance in European cereals, contributed to a double-digit increase in fungicide sales, with AMISTAR® exceeding $500 million. Insecticides benefited from the roll-out of new combination products while solid growth in herbicides demonstrated the strength of this product line. Professional Products continued a record of top line growth driven largely by the expansion of seed treatment. Total sales of new products grew by 32 percent (CER) to reach $688 million with continuing growth in the CALLISTO® range ($289 million) and in ACTARA®/CRUISER® ($298 million) as well as the successful launch of ENVOKE® on cotton in the USA. The range rationalization program reduced sales by $49 million (CER) in 2004. This four year program, with a cumulative sales impact of $301 million, is now complete. EBITDA rose by 22 percent (CER) to $1463 million.

This excerpt taken from the SYT 6-K filed Jan 18, 2005.
Septoria resistance.”

Syngenta is a world-leading agribusiness committed to sustainable agriculture through innovative research and technology. The company is a leader in crop protection, and ranks third in the high-value commercial seeds market. Sales in 2003 were approximately $6.6 billion. Syngenta employs some 19,000 people in over 90 countries. Syngenta is listed on the Swiss stock exchange (SYNN) and in New York (SYT). Further information is available at www.syngenta.com.

Media Enquiries: Switzerland:   Markus Payer Tel: +41 (61) 323 2323  
USA:   Sarah Hull Tel: +1 (202) 347 8348  
           
Analysts/Investors: Switzerland:   Jonathan Seabrook Tel: +41 (61) 323 7502  
  Jennifer Gough Tel: +41 (61) 323 5059  
USA:   Rhonda Chiger Tel: +1 (917) 322 2569  




Cautionary Statement Regarding Forward-Looking Statements
This document contains forward-looking statements, which can be identified by terminology such as ‘expect’, ‘would’, ‘will’, ‘potential’, ‘plans’, ‘prospects’, ‘estimated’, ‘aiming’, ‘on track’ and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefor.

 

 

Syngenta – 17 January 2005 / Page 1 of 1





SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

    SYNGENTA AG
         
Date: January 17, 2005 By: /s/ Damian Heller
     
      Name: Damian Heller
      Title: Company Secretary
         
         
    By: /s/ Daniel Michaelis
     
      Name: Daniel Michaelis
      Title: Senior Corporate Counsel
         

EXCERPTS ON THIS PAGE:

6-K
Jul 28, 2005
6-K
Feb 15, 2005
6-K
Jan 18, 2005

RELATED TOPICS for SYT:

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki